Membership fees
CORPORATE MEMBER
The following Societies can apply for Group Membership Payment:
- Indian Uveitis Society
- Israel Uveitis Society
- Japanese Ocular Inflammation Society
- Philippines Ocular Inflammation Society
- Malaysian Ocular Inflammation Interest Group
- Spanish Ocular Inflammation Society - SEOI
- Taiwan Uveitis Society
Contact the IOIS office to inform and/or apply for the Group Membership Payment.
---
Corporate Members are entitles to one seat in the international council and reduced registration for all for the meeting. Corporate members are not entitled for general assembly to vote (only regular members and 1 member of the society (usually the president).
---
Terms and conditions
Membership Payments should be made by credit card through our secured website, see privacy policy for more details.
play_circle_filled_white Privacy Policy
Cancellations and refunds
Refunds will not be granted for Memberships.
Membership Entitlement / Advantages
When becoming a member, you will be entitled to all IOIS privileges. These include receiving the Newsletter and participating in its edition, receiving the Guidelines books as these are published and the possibility to serve as a Panel Member in your field of expertise, to vote at the General Assembly* and be elected to all committees.
IOIS members are also entitled to reduced registration fees for the bi-annual congress.
- Reduced fee for symposia registration.
- Publication fee may be waived for selected invited articles in JOII - Journal of Ophthalmic Inflammation and Infection **.
** JOII - Please note that only a few papers will be free of charge each year. The final decision depends on the quality of the work submitted and decision will be taken by the Editor in Chief.
JOII - The Journal of Ophthalmic Inflammation and Infection is published in cooperation with the International Ocular Inflammation Society. The Society will cover the article processing charges for selected invited articles published in Journal of Ophthalmic Inflammation and Infection.